20162017201820192020202120222023Billable/Specific Code
- D68.312 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D68.312 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D68.312 – other international versions of ICD-10 D68.312 may differ.
ICD-10-CM D68.312 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Applicable To
- Lupus anticoagulant (LAC) with hemorrhagic disorder
- Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Type 1 Excludes
- antiphospholipid antibody, finding without diagnosis (R76.0)
- antiphospholipid antibody syndrome (D68.61)
- antiphospholipid antibody with hypercoagulable state (D68.61)
- lupus anticoagulant (LAC) finding without diagnosis (R76.0)
- lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D68.312:
- with > anticardiolipin R76.0
- hemorrhagic disorder > with D68.312
- with > antiphosphatidylglycerol R76.0
- hemorrhagic disorder > with D68.312
- with > antiphosphatidylinositol R76.0
- hemorrhagic disorder > with D68.312
- with > antiphosphatidylserine R76.0
- hemorrhagic disorder > with D68.312
- with > antiphospholipid R76.0
- hemorrhagic disorder > with D68.312
- antibody > Antiphospholipid
- with hemorrhagic disorder > antibody D68.312
- with > anticoagulant D68.62
- hemorrhagic disorder > with D68.312
- with > inhibitor (presence of) D68.62
- hemorrhagic disorder > with D68.312
